Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:1773-1778
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexiou, K.
Right arrow Articles by Stangl, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexiou, K.
Right arrow Articles by Stangl, K.

Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin

Aggravation of this phenomenon in heritable hyperlipidemia

Konstantin Alexiou, MDa, Thomas Dschietzig, MDa, Oliver Simscha, Michael Laule, MDa, Johannes Hundertmarka, Gert Baumann, MDa and Karl Stangl, MDa

a Medizinische Klinik und Poliklinik I, Charité, Humboldt-Universität zu Berlin, D-10098 Berlin, Germany



View larger version (43K):

[in a new window]
 
Figure 1 Incidence of VES during 40 min of separate perfusion and an additional 40 min of serial perfusion in NZW (n = 12) and WHHL (n = 8) rabbits. During serial perfusion, isolated hearts are perfused with the effluent of the same animal’s isolated lung. To exclude flow-dependency of arrhythmias, mechanical flow reduction (i.e., volume-controlled perfusion) comparable to the effects seen during serial perfusion was performed in isolated NZW and WHHL hearts (M-NZW, New Zealand mechanical flow reduction group; M-WHHL, Watanabe mechanical flow reduction group, n = 6 for both groups). ##, p < 0.01 vs. separate perfusion.

 


View larger version (42K):

[in a new window]
 
Figure 2 Incidence of VES in NZW and Watanabe hearts when serial perfusion (40 min) was conducted in the presence of PD-145065 (nonselective ET antagonist, 10 µmol/liter), A-127722 (ETA antagonist, 20 µmol/liter), BQ-123 (ETA antagonist, 2 µmol/liter) and phosphoramidon (Phrd, ECE inhibitor, 50 µmol/liter) (n = 6 per group). #, p < 0.05; ##, p < 0.01 vs. separate perfusion; *, p < 0.05; **, p < 0.01 vs. serial perfusion without intervention.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement